Skip to main content
OpenTrials
Completed

NCT Number: NCT01853527

Myocardial Ischemia in Non-obstructive Coronary Artery Disease

The aim of the study is to assess presence of myocardial ischemia by contrast stress echocardiography in patients with symptomatic non-obstructive coronary artery disease (CAD) by CT-coronary angiography, and the clinical, vascular, biochemical and genetic markers of myocardial ischemia in such patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Heart Disease, Haukeland University Hospital

Bergen, 5021, Norway

About this study

Non-obstructive coronary artery disease (CAD) is particularly common in women and associated with reduced quality of life and increased cardiovascular morbidity and mortality. The project will recruit patients with angina pectoris and non-obstructive CAD by CT- coronary angiography for further imaging with contrast stress echocardiography for diagnosis of myocardial ischemia. Better characterization of patients with symptomatic non-obstructive CAD due to myocardial ischemia will be done by vascular assessment by tonometry, biochemical and genetic markers as well as quality of life questionnaire. This interdisciplinary project is expected to add new knowledge to the impact of multimodality cardiac imaging in improving diagnosis in patients with symptomatic non-obstructive CAD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >30 years
  • Chest pain and or functional dyspnoea with a duration > 6 months
  • Non-obstructive coronary artery disease detected by CT coronary angiography

Exclusion criteria

  • Significant coronary artery stenosis or normal coronary arteries by CT coronary angiography
  • Unstable coronary artery disease
  • Significant valvular heart disease
  • Mechanical valve prosthesis
  • Significant arrhythmia
  • Severly reduced pulmonary function (GOLD 3-4)
  • Known allergy to ultrasound contrast agents
  • Pregnancy
  • Inability to sign informed consent to participate
  • Other severe disease

Treatment and study plan

Primary outcomes

  1. Presence of myocardial ischemia by contrast stress echocardiography

    Time frame: 15 minutes, during contrast stress echocardopgraphy

    Presence of delayed myocardial contrast enhancement during stress echocardiography

Secondary outcomes

  1. Extent of myocardial ischemia by contrast stress echocardiography

    Time frame: 15 minutes, during contrast stress echocardiography

    Numbers of left ventricular segments with delayed contrast enhancement during stress echocardiography

Sponsors and collaborators

Lead sponsor

University of Bergen

Other

Collaborators

  • Haukeland University Hospital

Registry information

Acronym: MicroCAD

Important dates

Study start
2013
Primary completion
2015
Study completion
2017
First posted
May 15, 2013
Registry last updated
Nov 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.